Table 2 Clinical characteristics, laboratory and echocardiographic findings of the groups
From: Evaluation of index of cardiac-electrophysiological balance in patients with subarachnoid hemorrhage
Patients with SAH | Control group | p-value | |
|---|---|---|---|
(n = 50) | (n = 50) | ||
Age (years) | 53,84 ± 15,5 | 57,34 ± 13,7 | 0,342 |
Gender, male, n % | 35 (70) | 30(60) | 0,412 |
BMI (kg/m²) | 28,65 ± 2,45 | 26,75 ± 2,54 | 0,086 |
Smokers, n, (%) Pulse-oximeter (SaO2) | 28(56) 96,84 ± 4,93 | 24(48) 98,02 ± 1,86 | 0,568 0,264 |
Systolic BP (mmHg) | 172,68 ± 36,4 | 164,48 ± 40,56 | 0,486 |
Diastolic BP (mmHg) | 96,52 ± 16,3 | 92,45 ± 14,8 | 0,536 |
IVS (mm) | 11,58 ± 0,62 | 11,24 ± 0,58 | 0,482 |
PW (mm) | 8,43 ± 1,16 | 8,12 ± 1,14 | 0,348 |
LVEF (%) AST (u/L) ALT (u/L | 6043 ± 3,18 32,74 ± 14,28 30,56 ± 12,8 | 60,52 ± 2,94 30,26 ± 13,56 28,64 ± 16,48 | 0,214 0,084 0,054 |
Creatinine (mg/dL) | 0,72 ± 0,22 | 0,6 ± 0,25 | 0,356 |
Potassium (mmol/L) | 4,18 ± 0,56 | 4,23 ± 0,52 | 0,482 |
Calcium (mg/dL) | 9,56 ± 0,35 | 9,65 ± 0,38 | 0,562 |
Magnesium (mg/dL) | 2,03 ± 0,26 | 2,11 ± 0,24 | 0,228 |
Fasting glucose (mg/dL) | 99,84 ± 12,82 | 95,68 ± 14,36 | 0,324 |
Thyroid stimulating hormone (µU/mL Glasgow coma scale Fisher score | 2,48 ± 1,18 11,08 ± 4,03 3,18 ± 0,84 | 2,28 ± 1,26 15,00 ± 0,00 1,00 ± 0,00 | 0,086 < 0,001 < 0,001 |